Cothera Bioscience
PrivateLast Round
Series B
Dec 23, 2020
Total Funding Raised
$35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cothera Bioscience operates in Healthcare & Life Sciences and is based in San Mateo, California. Its latest recorded funding round was a Series B round in December 2020.
Cothera Bioscience is a biotechnology company that develops targeted cancer therapies for previously undruggable targets, leveraging a platform based on synthetic lethality and protein degradation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cothera Bioscience Comparables
Compare Cothera Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenFleet Therapeutics | 80% | |
| Kronos Bio | 77% | |
| Monte Rosa Therapeutics | 77% |
For institutional investors. Book with your work email.
Cothera Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 23, 2020 | ||||
| Series A | Jul 1, 2017 |
For institutional investors. Book with your work email.
Cothera Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Star | Series B |
| 招银国际金融有限公司 | Series B |
| Legend Capital | Series B |
| Lang Sheng Investment | Series B |
| Sherpa Healthcare Partners | Series B |
| Harbinger Venture Capital | Series B |
| Qiming Venture Partners | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 68% MoM, from 1.2K to 2K.
- Jul 26, 2026
Monthly visitors grew 226% MoM, from 372 to 1.2K.
For institutional investors. Book with your work email.
Cothera Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cothera Bioscience's valuation, stock price, and market status.
Is Cothera Bioscience a public or private company?
Cothera Bioscience is a private company.
What is the current stock price of Cothera Bioscience?
Cothera Bioscience is a private company, so its shares have no public market price. Caplight tracks Cothera Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cothera Bioscience worth (valuation)?
Valuation information for Cothera Bioscience is not publicly available.
Can I buy Cothera Bioscience stock?
Cothera Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cothera Bioscience's last funding round?
Cothera Bioscience's most recent funding round was Series B on December 23, 2020.
Who are the main investors in Cothera Bioscience?
Key investors in Cothera Bioscience include Qiming Venture Partners.
Will Cothera Bioscience IPO soon?
No public IPO plans have been announced for Cothera Bioscience.
How can I track Cothera Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Cothera Bioscience's shares on secondary markets.